Advertisement

Topics

EMA's PRAC limits use of MS drug Zinbryta due to liver safety concerns

08:52 EDT 4 Aug 2017 | BioCentury

Original Article: EMA's PRAC limits use of MS drug Zinbryta due to liver safety concerns

NEXT ARTICLE

More From BioPortfolio on "EMA's PRAC limits use of MS drug Zinbryta due to liver safety concerns"

Quick Search
Advertisement